Create
Log in
Enquire now
Aerska
RNA medicines developer to treat, delay, and prevent diseases of the brain.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Organization
Company
CEO
Jack O'Meara
Country
United Kingdom
Republic of Ireland
Email Address
Sign up to view
Founded Date
2025
Founder
Stuart Milstein
David Hardwicke
Jack O'Meara
Headquarters
Dublin
Industry
Pharmaceutical industry
Health technology
Biotechnology
Investors
Ada Ventures
BlueYard Capital
BACKED VC
Speedinvest
Norrsken VC
PsyMed Ventures
Saras Capital
Lingotto
Kerna Ventures
Age1
•••
Latest Funding Round Date
February 10, 2026
Latest Funding Round Amount (USD)
39,000,000
Latest Funding Type
Series A
LinkedIn URL
@company/aerska
Location
London
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
60,000,000
Official Website
aerska.com
Find more companies like Aerska
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Pricing
Enterprise
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE